FLPIM
CRDF icon

F.L. Putnam Investment Management’s Cardiff Oncology CRDF Stock Holding History

F.L. Putnam Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
247,474
-347,653
-58% -$552K ﹤0.01% 545
2026
Q1 		$964K Sell
595,127
-201
-0% -$413 0.01% 328
2025
Q4 		$1.67M Sell
595,328
-1,905
-0.3% -$4.42K 0.02% 272
2025
Q3 		$1.23M Buy
597,233
+543,370
+1,009% +$1.5M 0.02% 312
2025
Q2 		$170K Buy
+53,863
New +$164K ﹤0.01% 568

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

F.L. Putnam Investment Management's CRDF Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its Cardiff Oncology (CRDF) stake by 58% in Q2 2026, selling an estimated $552K and leaving 247,474 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

F.L. Putnam Investment Management first reported a position in CRDF in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.67M in Q4 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • F.L. Putnam Investment Management held 247,474 shares of Cardiff Oncology worth $322K as of Q2 2026.
  • F.L. Putnam Investment Management sold 347,653 Cardiff Oncology shares in Q2 2026, an estimated $552K.
  • Cardiff Oncology made up ﹤0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #545 holding.
  • F.L. Putnam Investment Management first reported a position in Cardiff Oncology in Q2 2025 and has held it in 5 quarters since.
  • F.L. Putnam Investment Management's Cardiff Oncology position peaked at $1.67M in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.